Sandesh Seth, Executive Chairman at Actinium Pharmaceuticals, Inc. (ATNM), bought 5,000 shares at $0.88 ($4K) on 2016-12-30, disclosed to the SEC on 2017-01-03.
Open-market purchase of $4k ATNM by Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ATNM | BUY | 2018-04-20 | $2K | — | Filing → |
| ATNM | BUY | 2017-08-04 | $25K | — | Filing → |
| ATNM | BUY | 2017-06-15 | $9K | — | Filing → |